NYSE : HNGE

Hinge Health, Inc. — Financial statements

Healthcare · Health Information Services · United States

Last price 116.9 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 9.43B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Hinge Health, Inc. (HNGE) reported revenue of 720.06M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023
Revenue720.06M587.86M390.40M292.73M
Cost of Revenue111.32M118.56M89.81M98.55M
Gross Profit608.75M469.30M300.59M194.18M
Selling, General & Admin385.67M646.46M230.97M214.63M
Research & Development129.07M368.14M100.84M110.06M
Other Operating Expenses337.00K1.08M
Operating Expenses515.07M1.02B331.81M324.69M
Operating Income93.67M-546.37M-31.22M-130.51M
Interest & Investment Income17.08M18.68M20.57M21.70M
Other Non Operating Income (Expenses)196.00K425.00K82.00K266.00K
EBT Excluding Unusual Items110.95M-527.26M-10.56M-108.55M
Merger & Restructuring Charges-691.00K
Pretax Income110.95M-527.26M-11.26M-108.55M
Income Tax Expense1.88M998.00K677.00K-405.00K
Net Income109.07M-528.26M-11.93M-108.14M
Preferred Dividends & Other Adjustments1.78M-104.17M
Net Income to Common107.28M-424.09M-11.93M-108.14M
Shares Outstanding (Basic)78.88M54.58M13.56M13.02M
Shares Outstanding (Diluted)80.65M54.58M13.56M13.02M
EPS (Basic)1.36-7.77-0.88-8.31
EPS (Diluted)1.34-7.77-0.88-8.31
Free Cash Flow290.12M170.73M47.96M-65.89M
Free Cash Flow Per Share3.603.133.54-5.06
Gross Margin84.54%79.83%77.00%66.33%
Operating Margin13.01%-92.94%-8.00%-44.59%
Profit Margin14.90%-72.14%-3.06%-36.94%
Free Cash Flow Margin40.29%29.04%12.29%-22.51%
EBITDA95.69M-544.24M-28.87M-128.39M
EBITDA Margin13.29%-92.58%-7.40%-43.86%
D&A For EBITDA2.02M2.13M2.35M2.13M
EBIT93.67M-546.37M-31.22M-130.51M
EBIT Margin13.01%-92.94%-8.00%-44.59%
Advertising Expenses53.60M37.30M23.80M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023
Cash & Equivalents286.22M208.00M300.79M234.95M
Short-Term Investments103.17M155.87M165.79M188.40M
Cash & Short-Term Investments389.39M363.86M466.57M423.36M
Receivables125.43M66.06M42.49M46.56M
Inventory16.77M15.64M10.87M13.29M
Prepaid Expenses35.38M30.93M23.91M14.36M
Other Current Assets76.38M57.41M39.59M32.31M
Total Current Assets643.35M533.90M583.45M529.88M
Property, Plant & Equipment17.77M17.35M16.99M22.48M
Long-Term Investments84.74M113.17M
Goodwill64.10M64.10M61.61M61.61M
Other Intangible Assets2.06M2.51M1.81M2.19M
Long-Term Deferred Tax Assets1.00M1.06M473.00K
Long-Term Deferred Charges11.34M9.65M5.46M1.92M
Other Long-Term Assets4.03M3.08M2.89M3.99M
Total Assets827.40M744.76M673.26M622.53M
Accrued Expenses43.99M44.87M23.32M25.67M
Current Portion of Leases4.25M4.22M3.81M4.64M
Current Income Taxes Payable9.08M6.17M2.12M8.20M
Current Unearned Revenue416.47M300.86M217.63M140.47M
Other Current Liabilities7.65M6.29M2.41M5.17M
Total Current Liabilities481.44M362.41M249.30M184.16M
Long-Term Leases1.63M3.82M7.26M11.10M
Total Liabilities483.07M366.23M256.56M195.25M
Additional Paid-In Capital1.32B1.23B88.10M86.75M
Retained Earnings-972.18M-1.05B-522.74M-510.80M
Comprehensive Income & Other-364.00K-20.00K68.00K60.00K
Total Common Equity344.33M178.66M-434.57M-423.99M
Shareholders' Equity344.33M378.54M416.70M427.28M
Total Liabilities & Equity827.40M744.76M673.26M622.53M
Total Debt5.88M8.04M11.07M15.73M
Net Cash (Debt)468.25M469.00M455.50M407.62M
Net Cash Per Share5.818.5933.6031.31
Filing Date Shares Outstanding80.69M78.76M16.38M15.96M
Total Common Shares Outstanding80.20M79.17M16.38M15.96M
Working Capital161.91M171.50M334.15M345.73M
Book Value Per Share4.292.26-26.53-26.57
Tangible Book Value278.17M112.05M-497.98M-487.79M
Tangible Book Value Per Share3.471.42-30.40-30.57
Machinery6.21M7.58M7.26M7.05M
Leasehold Improvements203.00K203.00K203.00K203.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023
Net Income109.07M-528.26M-11.93M-108.14M
Depreciation & Amortization2.02M2.13M2.35M2.13M
Other Amortization64.79M49.67M33.51M23.84M
Loss (Gain) From Sale of Investments739.00K361.00K537.00K-10.76M
Stock-Based Compensation82.80M643.01M739.00K1.65M
Provision & Write-off of Bad Debts1.89M3.06M5.41M4.86M
Other Operating Activities3.55M3.48M4.88M13.11M
Change in Accounts Receivable-28.03M-26.63M-1.34M-23.13M
Change in Inventory-2.78M-4.76M608.00K10.56M
Change in Accounts Payable25.00M29.41M-10.97M11.56M
Change in Unearned Revenue141.33M83.22M77.16M35.97M
Change in Other Net Operating Assets-109.60M-83.25M-51.95M-25.56M
Operating Cash Flow290.79M171.44M49.00M-63.91M
Capital Expenditures-666.00K-708.00K-1.04M-1.98M
Cash Acquisitions-4.00M
Sale (Purchase) of Intangibles-6.20M-5.36M-2.73M-2.64M
Investment in Securities-12.89M-103.70M22.09M6.12M
Investing Cash Flow-19.75M-113.76M18.31M1.50M
Issuance of Common Stock17.23M265.20M610.00K492.00K
Repurchase of Common Stock-239.28M-360.26M
Other Financing Activities-288.00K-55.41M-2.81M-3.49M
Financing Cash Flow-222.34M-150.47M-2.20M-3.00M
Net Cash Flow48.69M-92.79M65.11M-65.41M
Free Cash Flow290.12M170.73M47.96M-65.89M
Free Cash Flow Margin40.29%29.04%12.29%-22.51%
Free Cash Flow Per Share3.603.133.54-5.06
Levered Free Cash Flow299.65M406.80M68.94M
Unlevered Free Cash Flow299.65M406.80M68.94M
Cash Income Tax Paid2.71M1.56M
Change in Working Capital25.93M-2.01M13.50M9.41M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023
Market Capitalization9.44B3.66B
Enterprise Value8.97B3.37B
Last Close Price114.3246.45
Forward PE45.3030.32
PS Ratio12.856.22
PB Ratio26.639.66
P/TBV Ratio33.2632.63
P/FCF Ratio31.8921.42
P/OCF Ratio31.8221.33
EV/Sales Ratio12.205.73
EV/FCF Ratio30.2719.74
Debt / Equity Ratio0.020.020.030.04
Debt / FCF Ratio0.020.050.23
Net Debt / Equity Ratio-1.36-1.24-1.09-0.95
Net Debt / EBITDA Ratio-4.890.8615.783.17
Net Debt / FCF Ratio-1.61-2.75-9.506.19
Asset Turnover0.950.830.60
Inventory Turnover7.248.957.43
Quick Ratio1.071.192.042.55
Current Ratio1.341.472.342.88
Return on Equity (ROE)30.38%-132.86%-2.83%
Return on Assets (ROA)7.70%-48.16%-3.01%
Return on Capital Employed (ROCE)27.10%-142.90%-7.40%-29.80%
Earnings Yield1.14%-14.45%
FCF Yield3.14%4.67%
Buyback Yield / Dilution-267.86%-302.55%-4.16%